Inhibition of the p53 Y220C mutant by 1-Hydroxy-2- Methylanthraquinone derivatives: a novel strategy for cancer therapy
Ahire, V., Das, D., Mishra, K. P., Kulkami, G. and Ackland, L. 2016, Inhibition of the p53 Y220C mutant by 1-Hydroxy-2- Methylanthraquinone derivatives: a novel strategy for cancer therapy, Journal of Environmental Pathology, Toxicology and Oncology, vol. 35, no. 4, pp. 355-364, doi: 10.1615/JEnvironPatholToxicolOncol.2016012256.
Attached Files
Name
Description
MIMEType
Size
Downloads
Title
Inhibition of the p53 Y220C mutant by 1-Hydroxy-2- Methylanthraquinone derivatives: a novel strategy for cancer therapy
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.